---
schema_version: "secwatch.filing_event.v1"
accession: "0000929638-24-000283"
form_type: "8-K"
ticker: "ICU"
cik: "0001831868"
company_name: "SeaStar Medical Holding Corp"
filed_at: "2024-01-30T23:59:59+00:00"
generated_at: "2026-06-06T15:10:02.779709+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# SeaStar Medical raises $9.0M in registered direct offering and private placement of shares and warrants

## Summary
- Gross proceeds of approx. $9.0M from sale of common stock, pre-funded warrants, Series A and B warrants at combined price of $0.8302/unit.
- Offering includes 10,840,761 common shares (or pre-funded warrants) plus warrants for up to 16,261,142 additional shares.
- Maxim Group LLC acted as sole placement agent; offering expected to close on or about January 30, 2024.
- Institutional investor agreed to waive certain optional redemption rights on existing convertible notes for 60 days.

## SEC filing metadata
- accession: 0000929638-24-000283
- form_type: 8-K
- ticker: ICU
- cik: 0001831868
- company_name: SeaStar Medical Holding Corp
- filed_at: 2024-01-30T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 1.01, 3.02, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1831868/000092963824000283/0000929638-24-000283-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1831868/000092963824000283/a8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000929638-24-000283
- JSON: https://secwatch.observer/filing/0000929638-24-000283.json
- Plain text: https://secwatch.observer/filing/0000929638-24-000283.txt

## Key facts
- Material Agreements
  SeaStar Medical Holding Corp entered into Securities Purchase Agreement with a single institutional investor valued at approximately $9.0 million (effective 2024-01-26).
  - Action: entry
  - Agreement: equity purchase
  - Counterparty: a single institutional investor
  - Value: approximately $9.0 million
  - Effective: 2024-01-26
  source text: On January 26, 2024, SeaStar Medical Holdings Corporation (the “Company”) entered into a Securities Purchase Agreement (the “Purchase Agreement”) with a single institutional investor (the “Purchaser”), pursuant to which the Company will issue to the Purchaser, (i) in a registered direct offering, 6,304,545 shares of the Company’s common stock (the “Shares”), par value $0.0001 per share (“Common Stock”), and pre-funded warrants to purchase 4,536,216 shares of Common Stock (the “Pre-Funded Warrants”) with an exercise price of $0.0001 per share, and (ii) in a concurrent private placement, series A warrants to purchase 10,840,761 shares of Common Stock (the “Series A Common Warrants”) and series B warrants to purchase 5,420,381 shares of Common Stock (the “Series B Common Warrants” and together with the Series A Common Warrants, the “Common Warrants”) each with an exercise price of $0.8302.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1831868/000092963824000283/0000929638-24-000283-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.